Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lithium therapy and suicide risk.

A Nilsson1

  • 1Karsudden Hospital, Katrineholm, Sweden. agneta.nilsson@ka.dll.se

The Journal of Clinical Psychiatry
|March 12, 1999
PubMed
Summary
This summary is machine-generated.

Ongoing lithium treatment significantly reduces suicide risk in patients with mood disorders. Discontinuation of lithium increases suicide risk, highlighting its critical role in managing suicidal behavior.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How carbon monoxide adsorbs in different sites.

Physical review letters·2000
Same author

Alkaline sphingomyelinases and ceramidases of the gastrointestinal tract.

Chemistry and physics of lipids·2000
Same author

Wheezing following lower respiratory tract infections with respiratory syncytial virus and influenza A in infancy.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2000
Same author

Allopurinol in addition to 5-aminosalicylic acid based drugs for the maintenance treatment of ulcerative colitis.

Alimentary pharmacology & therapeutics·2000
Same author

Partitioning of peptides and recombinant protein-peptide fusions in thermoseparating aqueous two-phase systems: effect of peptide primary structure.

Journal of chromatography. B, Biomedical sciences and applications·2000
Same author

Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries.

Nature biotechnology·2000
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Pharmacology

Background:

  • Previous studies suggested lower suicide rates in patients treated at specialized lithium clinics.
  • This study investigated if these findings hold true in less selective treatment settings.

Purpose of the Study:

  • To examine the association between lithium treatment and suicide risk in patients with mood or schizoaffective disorders.
  • To determine if lithium discontinuation increases suicide risk.

Main Methods:

  • A cohort of 362 patients with mood or schizoaffective disorders in Göteborg, Sweden, were followed for 8 years.
  • The study analyzed patient-years on and off lithium treatment, including periods of discontinuation.

Main Results:

Related Experiment Videos

  • Suicide risk was significantly higher when off lithium (SMR = 29.0) compared to on lithium (SMR = 6.1).
  • The relative risk of suicide was 4.8 times higher during lithium discontinuation.
  • Ongoing lithium treatment was associated with a 77% reduction in suicide risk, while substance abuse increased risk by 284%.

Conclusions:

  • Ongoing lithium treatment appears to be associated with a lower suicide risk.
  • The exact mechanism (mood stabilization, patient selection, or direct effect of lithium) remains undetermined due to study design.
  • Results on lithium's influence on suicide rates require cautious interpretation due to methodological limitations.